Basic Search  |  Summaries  |  Advanced Search

Violation Tracker UK Parent Company Summary

Parent Company Name: Nordic Capital
Ownership Structure: privately held
Headquartered in: Sweden
Major Industry: private equity (including portfolio companies)
Specific Industry: private equity (including portfolio companies)
Penalty total since 2010£94,502,933
Number of cases: 6
Top Offence Groups (Groups Defined)Penalty TotalNumber of Cases
competition-related offences£94,502,9336
Top Offence TypesPenalty TotalNumber of Cases
price-fixing or anti-competitive practices£94,502,9336
Note: Parent-subsidiary linkages are based on current relationships and may vary from what was the case when a violation occurred.

Individual Penalty Cases:

Click on the company or penalty amount for more information on each case.

Download results as CSV or XML (maximum 1000; for access to larger downloads contact Phil Mattera)
CompanyOffence TypeYearAgencyPenalty Amount sort icon
Advanz Pharmaprice-fixing or anti-competitive practices2021UK-CMA£43,000,000
Advanz Pharmaprice-fixing or anti-competitive practices2021UK-CMA£40,900,000
Focus Pharmaceuticals Limited and Mercury Pharma Group Ltd. and Concordia Investments (Jersey) Ltd. and Advanz Pharma Corp. Ltd. et al.price-fixing or anti-competitive practices2022UK-CMA£7,288,853
Focus Pharmaceuticals Limited and Mercury Pharma Group Ltd. and Cinven Partners LLP et al.price-fixing or anti-competitive practices2022UK-CMA£1,843,380
Focus Pharmaceuticals Ltd. and Focus Pharma Holdings Ltd. and Mercury Pharma Group Ltd.price-fixing or anti-competitive practices2022UK-CMA£921,357
Focus Pharmaceuticals Limited and Focus Pharma Holdings Limitedprice-fixing or anti-competitive practices2022UK-CMA£549,343